Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.

Ji JD, Kim HJ, Rho YH, Choi SJ, Lee YH, Cheon HJ, Sohn J, Song GG.

Rheumatology (Oxford). 2005 Aug;44(8):983-8.

PMID:
15840591
2.

Prostaglandin J2 family and the cardiovascular system.

Sasaguri T, Miwa Y.

Curr Vasc Pharmacol. 2004 Apr;2(2):103-14. Review.

PMID:
15320511
3.

Inhibition of IL-4-inducible gene expression in human monocytes by type I and type II interferons.

Dickensheets HL, Donnelly RP.

J Leukoc Biol. 1999 Mar;65(3):307-12. Review.

PMID:
10080532
4.

15d-PGJ2: the anti-inflammatory prostaglandin?

Scher JU, Pillinger MH.

Clin Immunol. 2005 Feb;114(2):100-9. Review.

PMID:
15639643
5.

15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂, an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling.

Surh YJ, Na HK, Park JM, Lee HN, Kim W, Yoon IS, Kim DD.

Biochem Pharmacol. 2011 Nov 15;82(10):1335-51. doi: 10.1016/j.bcp.2011.07.100. Review.

PMID:
21843512
6.

Natural ligands of PPARgamma: are prostaglandin J(2) derivatives really playing the part?

Nosjean O, Boutin JA.

Cell Signal. 2002 Jul;14(7):573-83. Review.

PMID:
11955950
7.
8.
9.

Principles of interleukin (IL)-6-type cytokine signalling and its regulation.

Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller-Newen G, Schaper F.

Biochem J. 2003 Aug 15;374(Pt 1):1-20. Review.

10.

Roles of peroxisome proliferator-activated receptor gamma in cardiovascular disease.

Takano H, Komuro I.

J Diabetes Complications. 2002 Jan-Feb;16(1):108-14. Review.

PMID:
11872377
11.

Of JAKs, STATs, blind watchmakers, jeeps and trains.

Kerr IM, Costa-Pereira AP, Lillemeier BF, Strobl B.

FEBS Lett. 2003 Jul 3;546(1):1-5. Review.

12.

Physiological and Pathological Roles of 15-Deoxy-Δ12,14-Prostaglandin J2 in the Central Nervous System and Neurological Diseases.

Yagami T, Yamamoto Y, Koma H.

Mol Neurobiol. 2017 Mar 16. doi: 10.1007/s12035-017-0435-4. [Epub ahead of print] Review.

PMID:
28299574
13.

Prostaglandins and the regulation of tumor growth.

Bishop-Bailey D, Calatayud S, Warner TD, Hla T, Mitchell JA.

J Environ Pathol Toxicol Oncol. 2002;21(2):93-101. Review.

PMID:
12086407
14.

Cyclopentenone prostaglandin receptors.

Negishi M, Katoh H.

Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:611-7. Review.

PMID:
12432947
15.

[Contribution of interleukin 2 and interleukin 12 receptors in signal transduction during cell activation of the immune system].

Łyszkiewicz M, Pajtasz-Piasecka E.

Postepy Hig Med Dosw. 2002;56(6):707-31. Review. Polish.

PMID:
12661403
16.

The role of STATs in inflammation and inflammatory diseases.

Pfitzner E, Kliem S, Baus D, Litterst CM.

Curr Pharm Des. 2004;10(23):2839-50. Review.

PMID:
15379672
17.
18.
19.

Alpha-interferon and its effects on signalling pathways within cells.

Caraglia M, Vitale G, Marra M, Budillon A, Tagliaferri P, Abbruzzese A.

Curr Protein Pept Sci. 2004 Dec;5(6):475-85. Review.

PMID:
15581417
20.

Lineage-specific negative regulation of STAT-mediated signaling by proteolytic processing.

Nakajima H, Suzuki K, Iwamoto I.

Cytokine Growth Factor Rev. 2003 Oct;14(5):375-80. Review.

PMID:
12948521

Supplemental Content

Support Center